Personalized Music, Dreaming During Propofol Sedation

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19+
SponsorWonkwang University Hospital

About this trial

This randomized clinical trial will evaluate whether music delivered through closed-back headphones during intravenous propofol sedation affects dreaming and the overall sedation experience. Adults scheduled for elective procedures under spinal anesthesia or peripheral nerve block with propofol sedation will be randomly assigned to one of three groups: patient-selected preferred music, matched non-preferred music, or silence with identical headphones.

The main purpose of the study is to determine whether listening to music increases the occurrence of dream recall compared with silence, and whether personally preferred music makes recalled dreams more pleasant than matched non-preferred music. Dream recall and dream pleasantness will be assessed after recovery using a standardized interview. The study will also evaluate dream content, patient satisfaction, sedative and opioid requirements, hemodynamic variability, postoperative pain, nausea and vomiting, recovery time, and adverse events.

This study is intended to determine whether a simple, low-cost headphone-based music intervention can improve patient-centered quality of propofol sedation without compromising safety.

Eligibility criteria

Qualifiers

Adults aged 19 years or older.

Scheduled to undergo an elective procedure under spinal anesthesia or peripheral nerve block with intravenous propofol sedation.

American Society of Anesthesiologists physical status I to III.

Able to provide written informed consent.

Disqualifiers

Planned general anesthesia.

Severe hearing impairment that would interfere with the auditory intervention.

Major psychiatric instability or condition that may interfere with study participation or dream assessment.

Expected significant intraoperative bleeding.

Trial design

Treatments tested in this trial

  • Preferred Music
  • Matched Non-preferred Music
  • Silence Control

Treatment groups

300 Participants
are divided into 3 treatment groups

Sponsors and collaborators